SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today TOP TOP leadership signals positive longterm industry outlook while addressing nearterm operational headwinds FHI Federated Hermes posts 153 Q4 2025 EPS beat while shares dip 108 in todays trading